NCT07120945 2026-03-06
Embrace Gyn
Medtronic - MITG
Phase NA Recruiting
Clinical Trials
12 trialsNCT04154683 2026-01-15
GYNECOPTIC
Hospices Civils de Lyon
Phase NA Recruiting
NCT04756037 2026-01-08
SERENE
Sumitomo Pharma Switzerland GmbH
Phase 3 Active not recruiting
NCT05726786 2025-12-09
INCyst
Centre Hospitalier Universitaire Vaudois
Phase 3 Recruiting
NCT07210918 2025-11-24
Serum Trace Element Levels in Some Gynecological Diseases
Cumhuriyet University
Phase NA Completed
NCT04567771 2025-11-14
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
Mayo Clinic
Phase NA Recruiting
NCT07173127 2025-09-15
The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters
University Hospital, Geneva
Phase NA Recruiting
NCT06949124 2025-09-10
A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT06802198 2025-09-05
STORY
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Not yet recruiting
NCT06969664 2025-08-19
A Trial of SHR7280 in Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT05862272 2025-08-06
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
Phase 3 Recruiting
NCT06891690 2025-03-24
tDCS
Poznan University of Physical Education
Phase NA Recruiting